2D QSAR STUDY OF INDOLE DERIVATIVES AS SELECTIVE COX-2 INHIBITORS

The NSAIDs are popular in reducing acute and chronic inflammation as they have no abuse liability. QSAR (Quantitative structureactivity relationship) approach is a very useful and widespread technique for drug design. 2D QSAR models are based on descriptors derived from a twodimensional graph representation of a molecule. The 2D QSAR study was performed on selected twenty-four compounds from synthesized indole derivatives for elucidating the structural requirements for COX-2 inhibition using multiple linear regression method. Statistically, significant models were generated using VLife Molecular Design Suite 3.5 software. The physicochemical parameters contributed significantly to biological activity. Amongst all the models generated, model 3 was found to be best with high r 2 (squared correlation coefficient) of 0.9382. Model is robust as q 2 (crossvalidated squared correlation coefficient) value is also high as 0.8557 with good predictive power as indicated by pred_r 2 = 0.7443. The model showed two alignment independent (AI) descriptors T_2_O_0 and T_2_N_7 as well as two physicochemical descriptors –ve Potential Surface Area and SA Most Hydrophobic contributing for activity. The present study may prove to be helpful in the development and optimization of existing indole derivatives as antiinflammatory agents with selective COX-2 inhibition. INTRODUCTION: NSAIDs inhibit cyclooxygenase (COX), the enzyme responsible for the conversion of arachidonic acid to prostaglandins. COX exists in 2 isoforms. COX-1 is a ubiquitous constitutive isozyme producing prostaglandins responsible for homeostatic functions such as maintenance of GI mucosal integrity. COX-2 is largely a cytokine-induced isozyme producing prostaglandins that mediate pain and inflammation 1 . NSAIDs inhibit both COX-1 and COX-2 to

[1]  M. Abdelgawad,et al.  Synthesis, cyclooxygenase inhibition, anti-inflammatory evaluation and ulcerogenic liability of novel triarylpyrazoline derivatives as selective COX-2 inhibitors. , 2015, Bioorganic & medicinal chemistry letters.

[2]  Khaled R. A. Abdellatif,et al.  Synthesis, cyclooxygenase inhibition, and anti-inflammatory evaluation of novel diarylheterocycles with a central pyrazole, pyrazoline, or pyridine ring , 2015, Medicinal Chemistry Research.

[3]  Samir M. El-Moghazy,et al.  Novel pyrazolopyrimidine derivatives targeting COXs and iNOS enzymes; design, synthesis and biological evaluation as potential anti-inflammatory agents. , 2014, European journal of pharmaceutical sciences : official journal of the European Federation for Pharmaceutical Sciences.

[4]  B. Vidyapeeth,et al.  Development of Pyrimidine Derivatives as Selective Cox-2 Inhibitors , 2012 .

[5]  A. Zarghi,et al.  Selective COX-2 Inhibitors: A Review of Their Structure-Activity Relationships , 2011, Iranian journal of pharmaceutical research : IJPR.

[6]  Iva B. Stoyanova-Slavova,et al.  QSAR modeling, synthesis and bioassay of diverse leukemia RPMI-8226 cell line active agents. , 2010, European journal of medicinal chemistry.

[7]  A. Chakraborti,et al.  Progress in COX-2 inhibitors: a journey so far. , 2010, Current medicinal chemistry.

[8]  K. Bothara,et al.  Novel 4-(morpholin-4-yl)-N'-(arylidene)benzohydrazides: synthesis, antimycobacterial activity and QSAR investigations. , 2009, European journal of medicinal chemistry.

[9]  A. Husain,et al.  Fenbufen based 3-[5-(substituted aryl)-1,3,4-oxadiazol-2-yl]-1-(biphenyl-4-yl)propan-1-ones as safer antiinflammatory and analgesic agents. , 2009, European journal of medicinal chemistry.

[10]  A. S. Girgis,et al.  Facile synthesis of bis(4,5-dihydro-1H-pyrazole-1-carboxamides) and their thio-analogues of potential PGE(2) inhibitory properties. , 2009, European journal of medicinal chemistry.

[11]  Ashok Kumar,et al.  Synthesis and antiinflammatory activity of heterocyclic indole derivatives. , 2004, European journal of medicinal chemistry.